Location: Home
  • search
  • go
  • Relate News
  • 10/15/2020AffaMed Therapeutics merging with EverInsight
  • 10/15/2020NeoGenomics to Expand Pharma Services in China
  • 10/15/2020Eisai's sNDAs for Anti-Epileptic Drug Fycompa Accepted in China
  • 10/14/2020CDE Publicizes Eight NDAs for Proposed Priority Review Designation
  • 10/14/2020CDE Issues Two Clinical Guidelines for R&D and Clinical Research of An...
  • 10/14/2020NMPA Solicits Comments on the Draft Measures for Compulsory Vaccine Li...
  • 10/14/2020NMPA Solicits Comments on the Amended Measures for the Administration ...
  • 10/14/2020Hainan Announces First QFLP Fund, Insurance to Cover Foreign Anti-Canc...
  • 10/13/2020Overview of China's Internet-Based Medicine
  • 10/13/2020KBR: Medytox Suspected of Illegally Selling BTX in China
  • 10/13/2020Rhizen Pharma and Curon Biopharma Enter License Deal for Tenalisib in ...
  • 10/13/2020Immunotherapy Company 3D Medicines Raises Funds After Spin-Off
  • 10/13/2020China: BMI Fund Cannot Afford to Cover Vaccinations
  • 10/13/2020NMPA Issues the Announcement on Infrastructural Building for IT Tracin...
  • 10/13/2020CDE Issues the Technical Guidelines for Clinical Evaluation of Radioac...
  • 10/13/2020CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 10/13/2020SAMR Solicits Comments on the Draft Guide to Antimonopoly in the Bulk ...
  • 10/13/2020CRO PPD Opens New Clinical Research Lab in Suzhou
  • 10/13/2020China Reviews Proposed Drug Patent Link Related Amendment to the Paten...
  • 10/12/2020CDE Issues the Clinical Requirements for Drugs Marketed Outside China ...
  • 10/12/2020Antengene Establishes New Drug Discovery Center in Shanghai
  • 10/12/2020HitGen to Acquire Vernalis for $25M in Cash
  • 10/12/2020China Sharpens Focus on Healthcare Cost Containment amid a Basket of M...
  • 10/11/2020CStone Announces Completion of $200 million Share Sale to Pfizer
  • 10/11/2020Antengene Announces Collaboration with WuXi Biologics to Advance the D...
  • 10/11/20202020 Fall/Winter Promotion - Pharma China publications
  • 10/10/2020Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...
  • 10/10/2020CDE Seeks Comments on Draft ICH Guideline E14-S7B
  • 10/10/2020NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...
  • 10/9/2020Everest Medicines Launches IPO in Hong Kong
  • Page:217/775 Total number of articles:23233: [First][<<] [215] [216] [217] [218] [219] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group